Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Metabolic medicine

Staying Healthy Long-Term: Monitoring and Survivorship

At a Glance

Abetalipoproteinemia requires individualized, lifelong follow-up to monitor vitamin levels, blood clotting, vision, nerve function, liver health, and bone density. Coordinated specialists, planned adult-care transition, and emotional support help manage risks through adulthood.

Managing abetalipoproteinemia (ABL) is a lifelong journey that shifts focus as you transition from childhood into adulthood. While early treatment with high-dose vitamins and a low-fat diet is vital for preventing complications, consistent long-term monitoring—often called surveillance—is the key to maintaining your quality of life and catching new issues before they become serious [1][2].

Your Lifetime Monitoring Schedule

Because ABL can affect multiple systems, your care requires a “team approach” involving several specialists. There is no universally applicable schedule; the intervals below are examples, and your team will individualize your monitoring based on your age, symptoms, and medication adjustments.

Specialty Common Tests Example Frequency (Individualized) Why It’s Important
Metabolic/Primary Care Blood Work: Vitamins A, D, E, K; Lipid Panel; CBC; Coagulation (PT/INR) Every 6–12 months (or individualized) [1][3] To ensure your vitamin doses are effective and your blood is clotting properly (PT/INR is a functional coagulation test) [4].
Ophthalmology Dilated Eye Exam; OCT (if indicated) Annually (or individualized) [5] To screen for retinitis pigmentosa-like changes and choroidal neovascularization (abnormal blood vessel growth) [6].
Neurology Comprehensive Neuro Exam; Strength & Balance Testing Annually (or individualized) [1][7] To monitor for ataxia (balance issues) or nerve damage (neuropathy) that can emerge in adulthood [1].
Hepatology (Liver) Liver Enzymes (ALT/AST); Abdominal Ultrasound Annually (or individualized) [8][9] To watch for hepatosteatosis (fatty liver). Note that liver enzymes can be normal despite steatosis, and ultrasound alone does not stage fibrosis [9].
Endocrinology DEXA Scan (Bone Density) Every 1–3 years (based on risk/individualized) [9] To monitor for osteopenia or osteoporosis caused by long-term Vitamin D deficiency [10].

Navigating Specific Long-Term Risks

As you age with ABL, two areas require particular vigilance: your vision and your liver health.

  • Choroidal Neovascularization (CNV): This is a complication where new, fragile blood vessels grow under the retina. Unlike the gradual vision loss of retinitis pigmentosa, CNV can cause rapid changes in your sight. If caught early, it is often treatable [6][5].
  • Liver Health: Because fat export from the liver is impaired in ABL, it can build up over time (hepatosteatosis) [8]. While many patients remain stable for decades without major liver issues, your team will use ultrasounds and blood tests to ensure this buildup doesn’t lead to inflammation or scarring [7][9].

Transitions of Care

As you mature, care coordination is critical:

  • Pediatric to Adult: Transferring care involves ensuring adult specialists understand this exceptionally rare condition.
  • Pregnancy and Genetics: Reproductive counseling is essential. Vitamin A doses may be teratogenic (harmful to a fetus) and must be adjusted, and genetic counseling can help you understand inheritance and carrier risks for family planning [11].

The Emotional Impact of “One-in-a-Million”

Living with a rare condition that requires a strict, lifelong diet and dozens of daily supplements can take a significant emotional toll. “Treatment fatigue”—feeling overwhelmed by the demands of managing your health—is a common and valid experience [11].

  • Dietary Social Stress: Constant vigilance over fat intake can make social situations, like dining out or holiday gatherings, feel stressful or isolating [11].
  • Mental Health Support: It is helpful to incorporate mental health support into your long-term care plan. Speaking with a therapist who understands chronic illness or joining a rare-disease support group can help you navigate the anxiety and isolation that sometimes accompany an ABL diagnosis [11].

By staying consistent with your individualized monitoring and being honest with your team about both your physical and emotional health, you can successfully manage ABL long into adulthood [7][9].

Common questions in this guide

How often should I be monitored for abetalipoproteinemia?
There is no single schedule for everyone. Blood tests are often checked every 6–12 months, eye, neurologic, and liver reviews are often annual, and bone-density scans may be repeated every 1–3 years when appropriate. Your clinicians may change these intervals based on age, symptoms, vitamin levels, and treatment changes.
Why do I need regular eye exams or an OCT scan with ABL?
Eye exams can look for retinal changes resembling retinitis pigmentosa and for choroidal neovascularization, in which fragile new blood vessels grow beneath the retina. This blood-vessel complication can cause rapid vision changes and may be treatable when found early. OCT is used when your ophthalmologist thinks a closer retinal assessment is needed.
How is liver health checked if my liver enzymes are normal?
Abdominal ultrasound and liver enzyme blood tests are commonly used to watch for hepatosteatosis, or fatty liver. Enzymes can remain normal even when fat is present, and an ultrasound alone cannot determine the amount of scarring. Your liver specialist may recommend additional assessment based on your results and risks.
Why might I need a DEXA scan with abetalipoproteinemia?
Long-term vitamin D deficiency can weaken bones and contribute to osteopenia or osteoporosis. A DEXA scan measures bone density and helps the care team decide how closely to follow bone health. Repeat testing may be considered every 1–3 years depending on individual risk.
How should care transition from pediatric to adult medicine be managed?
The transition should be planned with a coordinated team so adult clinicians understand ABL, past complications, vitamin doses, diet, and monitoring needs. Sharing records and identifying who will coordinate specialists can reduce gaps in care. The timing and specific clinicians depend on the patient’s age, symptoms, and local services.
What should I know about pregnancy and abetalipoproteinemia?
Pregnancy planning should include metabolic and genetic counseling. Vitamin A can harm a developing fetus at some doses, so the treatment plan may need adjustment before conception and during pregnancy. Do not change supplements without guidance from the clinicians managing your ABL.
How can I cope with the emotional burden of lifelong ABL care?
Strict dietary limits and many daily supplements can cause treatment fatigue, social stress, or isolation. A therapist familiar with chronic illness or a rare-disease support group may provide practical and emotional support. Tell your care team if treatment feels overwhelming or social situations are causing distress, so support can be added.

Get notified when new evidence is published on Abetalipoproteinemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Current Diagnosis and Management of Abetalipoproteinemia.

    Takahashi M, Okazaki H, Ohashi K, et al.

    Journal of atherosclerosis and thrombosis 2021; (28(10)):1009-1019 doi:10.5551/jat.RV17056.

    PMID: 33994405
  2. 2

    Lipids Responsible for Intestinal or Hepatic Disorder: When to Suspect a Familial Intestinal Hypocholesterolemia?

    Sissaoui S, Cochet M, Poinsot P, et al.

    Journal of pediatric gastroenterology and nutrition 2021; (73(1)):4-8 doi:10.1097/MPG.0000000000003145.

    PMID: 33853111
  3. 3

    A novel mutation, Ile344Asn, in microsomal triglyceride transfer protein abolishes binding to protein disulfide isomerase.

    Valmiki S, Bredefeld C, Hussain MM

    Journal of lipid research 2025; (66(1)):100725 doi:10.1016/j.jlr.2024.100725.

    PMID: 39672332
  4. 4

    An Unusual Presentation of Hemorrhagic Disease in an Infant: A Probable Case of Abetalipoproteinemia.

    Sivamurukan P, Boddu D, Pulimood A, Agarwal I

    Journal of pediatric hematology/oncology 2021; (43(3)):e429-e430 doi:10.1097/MPH.0000000000001831.

    PMID: 32433446
  5. 5

    Ophthalmic diagnosis and optical coherence tomography of abetalipoproteinemia, a treatable form of pediatric retinal dystrophy.

    Khan AO, Basamh O, Alkatan HM

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2019; (23(3)):176-177 doi:10.1016/j.jaapos.2019.01.005.

    PMID: 30731125
  6. 6

    Abetalipoproteinemia with angioid streaks, choroidal neovascularization, atrophy, and extracellular deposits revealed by multimodal retinal imaging.

    Bijon J, Hussain MM, Bredefeld CL, et al.

    Ophthalmic genetics 2024; (45(6)):583-590 doi:10.1080/13816810.2024.2411290.

    PMID: 39373891
  7. 7

    Thirty-Three Years Follow-Up of a Greek Family with Abetalipoproteinemia: Absence of Liver Damage on Long-Term Medium Chain Triglycerides Supplementation.

    Triantafillidis JK, Manioti A, Pittaras T, et al.

    Journal of personalized medicine 2025; (15(8)) doi:10.3390/jpm15080354.

    PMID: 40863416
  8. 8

    A novel p.Gly417Valfs*12 mutation in the MTTP gene causing abetalipoproteinemia: Presentation of the first patient in Mexico and analysis of the previously reported cases.

    Rodríguez Gutiérrez PG, González García JR, Castillo De León YA, et al.

    Journal of clinical laboratory analysis 2021; (35(3)):e23672 doi:10.1002/jcla.23672.

    PMID: 33258201
  9. 9

    Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins.

    Le R, Zhao L, Hegele RA

    Journal of clinical lipidology 2022; (16(2)):155-159 doi:10.1016/j.jacl.2022.02.003.

    PMID: 35221233
  10. 10

    Low cholesterol states: clinical implications and management.

    Gill PK, Hegele RA

    Expert review of endocrinology & metabolism 2023; (18(3)):241-253 doi:10.1080/17446651.2023.2204932.

    PMID: 37089071
  11. 11

    Guidance for the diagnosis and treatment of hypolipidemia disorders.

    Bredefeld C, Hussain MM, Averna M, et al.

    Journal of clinical lipidology 2022; (16(6)):797-812 doi:10.1016/j.jacl.2022.08.009.

    PMID: 36243606

This page is for informational purposes only and does not constitute medical advice. Your metabolic, primary care, and specialist team should personalize monitoring, vitamin doses, diet, and pregnancy planning for your situation.